FDA Brief

Company record

AcelRx Pharmaceuticals, Inc.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about AcelRx Pharmaceuticals, Inc..

Warning letters

  1. AcelRx Pharmaceuticals, Inc.

    FDA says AcelRx's DSUVIA banner and display ads misbrand the opioid tablet by oversimplifying dosing and understating risks.

    High risk